Abstract-Extracorporeal CO 2 Removal device is used in clinics when a patient suffers from a pulmonary insufficiency like Acute Respiratory Distress Syndrome and allows to decarboxylate blood externally. In this work, a model of the respiratory system coupled with such a device is proposed to analyze the decrease of CO 2 partial pressure in blood. To validate the model, some parameters are estimated thanks to experimental data. Metabolism is a crucial parameter and we show that its time evolution must be taken into account in order to have correct CO 2 partial pressure simulations in arteries and in veins.
I. INTRODUCTION
Acute Lung Injuries (ALI) or Acute Respiratory Distress Syndrome (ARDS) are still life threatening despite new strategies in mechanical ventilations [1, 2, 3] . In a clinical environment, a patient with ARDS is typically ventilated with low tidal volumes (6ml/kg) and a driving pressure (maximal pressure) below 30 cmH 2 O. This technique, named as protective ventilation strategy, is important to reduce ventilator-induced lung injuries [4] . To increase the oxygen partial pressure, high inspiratory fraction of O 2 is used and positive end-expiratory pressure (PEEP) allows to open alveoli. However, because of the low tidal volumes, the CO 2 partial pressure is not sufficiently reduced, leading to hypercapnic acidosis, a deleterious condition for the global physiology including the lung and the pulmonary circulation. Indeed, hypercapnic acidosis induces pulmonary vasoconstriction and, consequently, pulmonary hypertension. Moreover, pulmonary hypertension can have severe repercussions on the right ventricle because of its high sensitivity to changes in pulmonary hemodynamics [5, 6] . For these reasons, pulmonary hypertension and hypercapnic acidosis must be strictly controlled. In the case of hypertension, the driving pressure and the PEEP can be adapted on the ventilator [6] . For hypercapnic acidosis, a veno-venous ExtraCorporeal Membrane Oxygenator (vv-ECMO) is often used. When ARDS is not too severe (PaO 2 /FIO 2 > 100 mmHg [7] , where PaO2 is the arterial partial pressure in O 2 and FIO 2 is the inspired oxygen fraction), the aim of the strategy is to decrease the CO 2 partial pressure without being too invasive. In this case, the ECMO must rather be considered as a low flow extracorporeal CO 2 removal device (ECCO 2 RD, see Figure 1 ).
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The aim of the present work is to develop such a model, simple enough to be solved in real-time in a clinical environment. Our model is derived from the works of Batzel et al. [8] and Karbing et al. [9] . A pulmonary shunt is taken into account in parallel with the lungs and the modelling of the ECCO 2 RD consists in adding a second "lung compartment", which is perfused by a fraction of the systemic blood flow extracted in the inferior vena cava and reinjected in the atrium, after crossing the device (see Figure  1 ). We estimate the parameters of the model and emphasize the role of the metabolism whose value cannot be assumed constant during our experiments. Taking into account its variations, we show that our model provides a good description of the CO 2 time evolution and can thus be considered as an interesting tool that could help clinicians to improve the use of ECCO 2 RD.
II. METHODS
In this study, the respiratory system assisted by an ECCO 2 RD is reduced to a small number of "compartments" (lumped parameter model). We consider two compartments for the respiratory system: the lung and the tissues. In addition, a third compartment is added to model the ECCO 2 RD (see Figure 2) .
Importance of Metabolism Variations in a Model of Extracorporeal
Carbon Dioxide Removal* S. Habran, Th. Desaive, Ph. Morimont, B. Lambermont and P.C. Dauby Figure 2 . Respiratory model assisted by an ECCO2RD. The symbols fS and fd are respectively the pulmonary shunt fraction and the fraction of cardiac blood flow (QC) which crosses the ECCO2RD. The symbols Ca,i , Cv,i , Cd,i , Crv,i and Cl,i denote respectively the blood concentrations for component i in arteries, in veins, after the ECCO2RD, in the right ventricule and in the lung.
A. Model of the respiratory system
Our mathematical model of pulmonary gas exchanges and tissues gas exchanges is based on the work of Batzel et al. [8] . This model considers that diffusion of O 2 and CO 2 through the alveolar-capillary membrane is fast so that equilibrium can be assumed between the alveoli and the capillaries at the end of pulmonary capillaries. To include pulmonary gas exchanges abnormalities, additional parameters and additional equations are required. ARDS is a complex phenomenon and some authors describe this pathology by dividing the lung into 2 compartments to model ventilation/perfusion mismatch [9, 11] . Since the identification of the parameters of these 2 compartments is not easy (and even impossible in our case with the available experimental data), we will use a simpler description. A pulmonary shunt and a dead volume will be used whose importance will determine the global quality of gas exchanges and which will thus allow to model lung injuries in a simple way. In the tissues, O 2 is consumed and CO 2 is produced by the metabolism and these quantities are considered as parameters of our model. Different estimations of these parameters are possible and will be presented below.
B. Model of the ECCO 2 RD
The ECCO 2 RD is considered as a second lung compartment which takes a fraction of the systemic blood flow in the inferior vena cava and rejects the corresponding treated blood flow in the right atrium (see Figure 1) . However, it is important to mention that the diffusion of O 2 and CO 2 across the synthetic membrane of the device is much slower than across the lung membrane. For this reason, the equilibrium between the gas and the blood in the device is usually not reached. Therefore, we have to model the diffusion of O 2 and CO 2 between the gas and the blood across the synthetic membrane [12] . We assume that the flows of air and blood are one-dimensional but have opposite directions (see Figure 3 and see for instance [13] ). 
C. Blood chemistry model
In the blood, the relationships between partial pressures and total concentrations of gases are really complex. Indeed, O 2 is dissolved in blood plasma and also complexed with hemoglobin while CO 2 is dissolved in blood plasma, complexed with hemoglobin and subject to the hydratation reaction which couples CO 2 and HCO 3 -. Since the CO 2 partial pressure can vary very significantly, especially when a protective ventilation is used and when the medical device is switched on, we must consider the influence of the pH in blood plasma over the O 2 haemoglobin saturation curve. To take this into account in our approach, the relation between the O 2 concentration and the O 2 partial pressure is based on the work of Grodins et al. [14] . The relations between CO 2 concentration, pH in plasma and CO 2 partial pressure are based on the work of Trueb et al. [15] .
D. Estimations of CO 2 production and O 2 consumption by
the metabolism In a stabilized situation, the CO 2 production (MR CO2 ) can be estimated by:
where Q c is the cardiac output, C v,CO2 and C a,CO2 are respectively the total venous and arterial CO 2 concentrations (the venous concentration is measured in the inlet cannula of the ECCO 2 RD). The O 2 production (MR O2 ) can be determined similarly. Another estimation is possible by analyzing the gas expired out the ECCO 2 RD and gas expired out the ventilator : [16] .
In our experimental setup, the O 2 fractions in the ventilator and in the extracorporeal device are not available. Consequently, we will assume that MR O2 is equal to MR CO2 . Finally, note that standard rough estimations of CO 2 production and O 2 consumption can also be found in the literature with values around 7ml/min/kg [17] .
E. Experimental data
Experiments were carried out on 6 pigs, with the approval of the Ethics Committee of the Medical Faculty of the University of Liège. Protective ventilation was introduced for the pigs and extracorporeal CO 2 removal was used to decarboxylate the blood. Note that no true pulmonary insufficiencies were induced on the animals but adjustment of the parameters of the protective ventilation allows to mimic the impaired gas exchanges that take place in such situations.
Blood flow was measured with thermodilution technique (PiCCO ® , Pulsion, Germany) and with an admittance pressure-volume catheter (Transonic, USA). Tidal volume, PEEP, F I,O2 , respiratory frequency and driving pressure were fixed by the ventilator. Arterial and venous blood samples were analyzed with a RapidPoint500 ® (Siemens, Germany) during basal state, after the introduction of the protective ventilation and during the CO 2 removal procedure. In our experiments, the blood flow through the extracorporeal device was successively set to 200, 400 and 600 ml/min, which is referred to as ECCO2RD 200, ECCO2RD 400 and ECCO2RD 600 in Figures 4 and 5 .
Thanks to cardiac blood flow measurements, to analyses of blood samples in the arteries and given the parameters fixed by the ventilator, the pulmonary shunt can be estimated just before the ECCO 2 RD is switched on and we consider its value constant for the whole simulation.
III. RESULTS AND DISCUSSION
The results corresponding to 4 pigs are presented and discussed in this section. For the other 2 pigs, experimental issues occurred (cardiac arrest for pig 1 and blood clots in the cannula for pig 6), which made the analysis impossible in these cases.
A. Metabolism determination
For all pigs, some blood estimations of MR CO2 obtained from equation 7, and similar estimations of MR O2 , were too low to be physiological (below 0.05 l/min) and their values vary a lot for a same experimental state. On the other hand, gas estimations of MR CO2 obtained from equation 8 were more stable and their values were always in a physiological range. For these reason, only equation 8 will be used from now on to characterize the evolution of metabolism. and an initial value of MR CO2 around 0.27 l/min). Finally let us mention that the decrease of metabolism in our experimental setting after switching on the ECCO 2 RD is probably mainly due to hypothermia induced by the absence of a heater in our device (see the example in Figure 4 ). 
B. Result of the model and comparison with experiments
Using the values of CO 2 production and O 2 consumption given in the previous section and taking into account the influence of the ECCO 2 RD, our model allows to determine the time evolution of the gas concentrations in the blood for pigs 2 to 5. The corresponding results are presented in Figure 5 , which shows the calculated curves describing the decrease of CO 2 partial pressure in arteries and in veins. The figure also shows the corresponding experimental points (crosses). The solid lines correspond to time varying metabolims, while the dotted lines were obtained by considering constant CO 2 gas production and constant O 2 consumption rates. These constant rates can be estimated by
-3 l/min, where W is the weight of the pig. It is then interesting to note that the obtained values are found to be close to the corresponding mean measured values. The comparison of the solid and dotted lines with the experimental results clearly shows that a much better model is obtained when the time variations of metabolism are taken into account. This is particularly true at the most left and right parts of the 4 panels of Figure 5 , since at these times, the metabolism production rates for the 2 simulations are quite different from each other.
IV. CONCLUSION
In this work, we have built and validated a mathematical model of the respiratory system assisted by an extracorporeal CO 2 removal device. The predictions of the model are shown to be in good agreement with experimental data provided that the time evolutions of CO 2 production and O 2 consumption by metabolism are taken into account. The time evolution of metabolism must thus be described carefully in models of the respiratory system assisted by extracorporeal devices.
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